Status:
COMPLETED
Contribution of Hypnosis in Guided Hepatic Biopsy (Ap-Hy-PBH)
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Ultrasound-guided Hepatic Biopsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the contribution of hypnosis on the level of pain felt by the patient during ultrasound-guided hepatic biopsy, by comparing an intervention group (hypnosis) to...
Detailed Description
Hepatic Biopsy Puncture (HBP) is a very useful procedure for the assessment of chronic liver disease as well as in certain acute situations, and is also essential in oncology for the histological diag...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with an indication for ultrasound-guided hepatic biopsy
- Over 18 years of age
- Affiliated to a social security system
- Exclusion Criteria
- History of psychiatric pathology, psychotropic or anxiolytic treatments
- Refusal to participate.
- People who do not understand and/or speak French.
- People who are deaf
- Patients with impaired cognitive abilities, evaluated by the prescribing service
- Disorders of hemostasis against percutaneous approach
- Allergy to Lidocaine
- Patient under National Health Aids
Exclusion
Key Trial Info
Start Date :
September 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 2 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05413174
Start Date
September 29 2022
End Date
June 2 2023
Last Update
December 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP
Paris, France, 75015